Related Experiment Video
Updated: Jun 5, 2026
Intranasal Delivery of Therapeutic Stem Cells to Glioblastoma in a Mouse Model
Published on: June 4, 2017
Molecular targeting of neural cancer stem cells: TTAGGG, you're it!
Anita B Hjelmeland1, Jeremy N Rich
1Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA.
Abstract:
Telomerase is an important mechanism by which cancers escape replicative senescence. In neural tumors, cancer stem cells express telomerase, suggesting that this may explain their preferential tumorigenesis. Oligonucleotide telomerase targeting selectively disrupts cancer stem cell growth through the induction of differentiation, adding to the armamentarium of anticancer stem cell therapies.
Insights
Telomerase enables cancer cells to avoid aging. Targeting telomerase in neural tumors halts cancer stem cell growth by inducing differentiation, a novel anticancer therapy.
Area of Science:
- Oncology
- Molecular Biology
- Stem Cell Research
Background:
- Telomerase is crucial for cancer cells to evade replicative senescence.
- Cancer stem cells (CSCs) in neural tumors express telomerase, contributing to their tumorigenic potential.
Purpose of the Study:
- To investigate the role of telomerase in neural tumors.
- To evaluate oligonucleotide telomerase targeting as a therapeutic strategy against CSCs in neural tumors.
Main Methods:
- Selective disruption of cancer stem cell growth.
- Induction of differentiation in cancer stem cells.
Main Results:
- Oligonucleotide telomerase targeting effectively disrupts CSC growth.
- The targeting strategy induces differentiation in neural tumor CSCs.
Conclusions:
- Telomerase targeting is a promising strategy for eliminating neural tumor stem cells.
- This approach expands the options for anticancer stem cell therapies.
